The Magnificent Seven, as a whole, may still be great long-term bets, especially now that most of their members have fallen under enough pressure to see their valuation metrics compress. That said, the Mag Seven seem to be breaking apart, with three members in Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), and Meta Platforms (NASDAQ:META) sinking, while two ... Forget the Mag 7. It’s All About the ...
The Magnificent Seven, as a whole, may still be great long-term bets, especially now that most of their members have fallen under enough pressure to see their valuation metrics compress. That said, the Mag Seven seem to be breaking apart, with three members in Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), and Meta Platforms (NASDAQ:META) sinking, while two ... Forget the Mag 7. It’s All About the Magnificent 2 and They’re Still Buys
creuxnoir/iStock via Getty Images Goldman Sachs expects the recent equity market broadening to continue in early 2026, but the magnitude and duration of that rotation will ultimately prove limited, according to Ben Snider, chief U.S. equity strategist and managing director at Goldman Sachs. Snider pointed to an improving economic outlook and favorable Federal Reserve policy as near-term tailwinds,...
creuxnoir/iStock via Getty Images Goldman Sachs expects the recent equity market broadening to continue in early 2026, but the magnitude and duration of that rotation will ultimately prove limited, according to Ben Snider, chief U.S. equity strategist and managing director at Goldman Sachs. Snider pointed to an improving economic outlook and favorable Federal Reserve policy as near-term tailwinds, though he cautioned that several factors will constrain how far this trend can extend. Building on momentum from late 2025, U.S. small-caps and mid-caps and non-U.S. markets have generally outperformed the headline U.S. equity indices ( SP500 ), ( COMP:IND ), ( DJI ) in the first few weeks of 2026, with the Russell 2000 ( IWM ) returning 10% year-to-date and outperforming the S&P 500 ( SP500 ) on each of the first 14 trading days of the year. From a fundamental perspective, the improvement in market breadth reflects a broadening in the opportunity set facing investors, driven by an improving economic growth outlook and friendly Fed policy, according to Goldman Sachs. US equity market breadth has improved sharply since October (FactSet, Goldman Sachs Global Investment Research) The shift also reflects continued portfolio diversification among investors, with the strategists emphasizing that “a rotation of 1% of S&P 500 ( SP500 ) market cap to the Russell 2000 ( IWM ) would represent 19% of market cap for the small-cap index.” While strong economic growth in the first half of 2026 creates larger near-term tailwinds for smaller and more cyclical stocks, the firm’s economists expect GDP growth will return to roughly trend in the second half of the year, limiting the runway for cyclical broadening. Goldman Sachs analysts also noted that valuations for the average S&P 500 stock are already elevated versus both history and fundamentals, presenting another constraint on extended outperformance. Snider identified three historical paths to extended broadening—a “catch down” in mega-...
Image source: The Motley Fool. Tuesday, July 29, 2025 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — J. Powell Brown Executive Vice President and Chief Financial Officer — R. Andrew Watts Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Total Revenue -- $1.285 billion, up 9.1%, driven by both organic expansion and acquisitions. -- $1.285 billion, u...
Image source: The Motley Fool. Tuesday, July 29, 2025 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — J. Powell Brown Executive Vice President and Chief Financial Officer — R. Andrew Watts Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Total Revenue -- $1.285 billion, up 9.1%, driven by both organic expansion and acquisitions. -- $1.285 billion, up 9.1%, driven by both organic expansion and acquisitions. Organic Revenue Growth -- 3.6% consolidated, with deceleration attributed to property rate pressure and lower new business in Retail. -- 3.6% consolidated, with deceleration attributed to property rate pressure and lower new business in Retail. Adjusted EBITDAC Margin -- 36.7%, an increase of 100 basis points, supported by incremental interest income and underlying margin expansion. -- 36.7%, an increase of 100 basis points, supported by incremental interest income and underlying margin expansion. Adjusted Diluted Earnings Per Share -- $1.03, up 10.8% on a higher share base. -- $1.03, up 10.8% on a higher share base. Retail Segment -- Organic growth of 3%, total revenue up 7.9%; margin decreased by 50 basis points to 27.5% due to Quintes revenue seasonality. -- Organic growth of 3%, total revenue up 7.9%; margin decreased by 50 basis points to 27.5% due to Quintes revenue seasonality. National Programs Segment -- 4.6% organic growth; total revenue up 6.1%; EBITDAC margin expanded by 320 basis points to 52.8%, aided by a contingent commission true-up. -- 4.6% organic growth; total revenue up 6.1%; EBITDAC margin expanded by 320 basis points to 52.8%, aided by a contingent commission true-up. Wholesale Brokerage Segment -- Organic growth of 3.9%, total revenue up 14.5%; margin increased by 80 basis points to 34.1%, with higher contingent income and acquisition mix impact. -- Organic growth of 3.9%, total revenue up 14.5%; margin increased by 80 basis points to 34.1%, with higher contingent income and acquisition mix i...
Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has been going on behind the scenes amid the intense sideways action. Of course, Nvidia isn’t solely to blame for the recent consolidation. In fact, the Magnificent Seven players have really run out ... NVIDIA Just Made a Bigger Push Into AI Drug Discovery
Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has been going on behind the scenes amid the intense sideways action. Of course, Nvidia isn’t solely to blame for the recent consolidation. In fact, the Magnificent Seven players have really run out ... NVIDIA Just Made a Bigger Push Into AI Drug Discovery
Image source: The Motley Fool. Thursday, July 24, 2025 at 1 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — James Eugene Beckwith Executive Vice President and Chief Financial Officer — Heather Christina Luck Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Net Income -- $14.5 million with reported earnings per share of $0.68. -- $14.5 million with report...
Image source: The Motley Fool. Thursday, July 24, 2025 at 1 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — James Eugene Beckwith Executive Vice President and Chief Financial Officer — Heather Christina Luck Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Net Income -- $14.5 million with reported earnings per share of $0.68. -- $14.5 million with reported earnings per share of $0.68. Return on Average Assets -- 1.37% for the quarter as disclosed in prepared remarks. -- 1.37% for the quarter as disclosed in prepared remarks. Return on Average Equity -- Reached 14.17% during the period. -- Reached 14.17% during the period. Net Interest Margin -- Expanded 8 basis points to 3.53% from the prior quarter. -- Expanded 8 basis points to 3.53% from the prior quarter. Cost of Total Deposits -- Declined by 2 basis points sequentially to 2.46%. -- Declined by 2 basis points sequentially to 2.46%. Efficiency Ratio -- Management cited a ratio of 41.03% for operating expenses to revenues. -- Management cited a ratio of 41.03% for operating expenses to revenues. Loans Held for Investment -- Increased by $136.2 million, equating to a 15% annualized rate. -- Increased by $136.2 million, equating to a 15% annualized rate. Total Deposit Growth -- Rose $158.3 million, representing a 17% annualized increase. -- Rose $158.3 million, representing a 17% annualized increase. Nonperforming Loans -- Represented 6 basis points of total loans, with an increase of $0.5 million attributed to one commercial real estate loan placed on nonaccrual status. -- Represented 6 basis points of total loans, with an increase of $0.5 million attributed to one commercial real estate loan placed on nonaccrual status. Dividend Declaration -- Board approved a $0.20 per share cash dividend, with payment anticipated in August. -- Board approved a $0.20 per share cash dividend, with payment anticipated in August. Commercial Real Estate Loan Portfolio -- Grew by $125.4 mill...
Specialty chemicals producer Archroma is readying for talks over an extension to its debt stack, as its results are improving following a period of weakness in its industry. The SK Capital -backed company released a preliminary earnings update last week, showing some signs of a gradual recovery in profits and cash flow generation, said people familiar with the matter, speaking on the condition of ...
Specialty chemicals producer Archroma is readying for talks over an extension to its debt stack, as its results are improving following a period of weakness in its industry. The SK Capital -backed company released a preliminary earnings update last week, showing some signs of a gradual recovery in profits and cash flow generation, said people familiar with the matter, speaking on the condition of anonymity. On the back of that, Archroma is considering starting formal discussions in coming weeks to amend and extend its term loans due in June 2027, said the people. The company has €555 million ($658 million) of euro loans and a $340 million dollar tranche maturing next year, according to data compiled by Bloomberg. The euro-denominated tranche is currently quoted at around 89 cents on the euro, after reaching a low of 74 in October, according to price data compiled by Bloomberg. Archroma held a non-deal roadshow in December, one of the people said. It has also had informal conversations with creditors about extending maturities, some of the people said. Among the options floated was raising second-lien debt the company could use to pay down some of the term loan, lowering first-lien leverage, they added. There is no guarantee that a deal will come together in coming weeks, and the company could also opt to address the maturities next quarter. A spokesperson for Archroma declined to comment. SK Capital did not respond to a request for comment. Headquartered in Switzerland, Archroma provides chemicals to the textiles, packaging and paper industries. Although the term loan doesn’t mature for over a year, it’s common for borrowers to seek to refinance their facilities well in advance of the redemption date. Those who don’t can face pressure from ratings agencies. In December, S&P Global Ratings slashed its credit score for Archroma to B-, flagging that it was expecting challenging market conditions in the chemicals space to last through 2026. The European chemicals indust...